Conaghan et al. LEVI-04, neurotrophin-3 inhibitor in knee OA. 518 patients. Significant improvements in WOMAC pain and function, and PGA. So sign of any increase in rapidly progressive OA (as with NGF inhibitors) @RheumNow #ACR24 Abstr#L15 https://t.co/qud4wTAikY https://t.co/0wjjG4U4bf
Links:
LEVI-04, a Novel neurotrophin-3 Inhibitor, Substantially Improves Pain and Func…
https://acrabstracts.org/abstract/levi-04-a-novel-neurotrophin-3-inhibitor-subs…
19-11-2024